Cargando…
Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
PURPOSE: To report the clinical course of our first 7 consecutive patients treated with intravitreal ocriplasmin (Jetrea(®)). METHODS: Retrospective case series of the first 7 patients treated with ocriplasmin between January and December 2013 at an academic tertiary care center. RESULTS: The averag...
Autores principales: | Chin, Eric K., Almeida, David R.P., Sohn, Elliott H., Boldt, H. Culver, Mahajan, Vinit B., Gehrs, Karen M., Russell, Stephen R., Folk, James C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296250/ https://www.ncbi.nlm.nih.gov/pubmed/25606039 http://dx.doi.org/10.1159/000370024 |
Ejemplares similares
-
Spontaneous Resolution of Vitreomacular Traction in Two Patients with Diabetic Macular Edema
por: Almeida, David R.P., et al.
Publicado: (2014) -
Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016) -
Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014) -
Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020) -
OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)